TranS1 names Reali as CEO

North Carolina-based TranS1 has appointed President and COO Ken Reali as its new CEO. TranS1 makes products for patients with lower back problems and hopes to capture a piece of the $7 billion spine surgery business with its AxiaLIF products for lumbar procedures, according to StarNewsOnline. The move comes roughly a year after Reali joined the company.

Prior to coming to TranS1, Reali worked at Smith & Nephew, where he spent five years in various senior marketing, sales and product development positions. He previously worked at Stryker and Biomet, according to a company statement.

Current CEO Rick Randall will continue to serve as a member of the board in the newly created position of executive chairman. Randall joined the company in 2002. Although TranS1 has yet to turn a profit, it narrowed its loss in the third quarter to $3.8 million from $5.6 million a year earlier, StarOnlineNews reports. Revenues were $6.3 million, compared with $6.9 million in the third quarter of 2009.

- get the TranS1 release
- check out more from StarNewsOnline

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.